Keisuke Koroki
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 2
- Oncology 6
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Sadahisa Ogasawara (17 shared papers)Naoya Kanogawa (15 shared papers)Takayuki Kondo (11 shared papers)Naoya Kato (11 shared papers)Shingo Nakamoto (10 shared papers)Masato Nakamura (14 shared papers)Hiroaki Kanzaki (12 shared papers)Tetsuhiro Chiba (11 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Scientific Reports (2 papers)Clinical and Molecular Hepatology (1 paper)JHEP Reports (1 paper)PLoS ONE (1 paper)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Keisuke Koroki
15 papers receiving 93 citations
Peers
Comparison fields: 5 of 25
- Hepatology 57
- Cancer Research 9
- Pulmonary and Respiratory Medicine 17
- Epidemiology 15
- Oncology 10
Countries citing papers authored by Keisuke Koroki
This map shows the geographic impact of Keisuke Koroki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Koroki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Koroki more than expected).
Fields of papers citing papers by Keisuke Koroki
This network shows the impact of papers produced by Keisuke Koroki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Koroki. The network helps show where Keisuke Koroki may publish in the future.
Co-authors
The 25 scholars most cited alongside Keisuke Koroki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 45 | |
| 2 | 2021 | 17 | |
| 3 | 2022 | 8 | |
| 4 | 2020 | 6 | |
| 5 | 2021 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2020 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2024 | 0 |
About Keisuke Koroki
Keisuke Koroki is a scholar working on Hepatology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 18 papers that have together received 95 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer Mechanisms and Therapy (2 papers), Lung Cancer Research Studies (2 papers), Liver Disease and Transplantation (2 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Hepatology (57 citations), Cancer Research (9 citations), Pulmonary and Respiratory Medicine (17 citations), Epidemiology (15 citations) and Oncology (10 citations). Keisuke Koroki has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Sadahisa Ogasawara, Naoya Kanogawa, Takayuki Kondo, Naoya Kato, Shingo Nakamoto, Masato Nakamura, Hiroaki Kanzaki, Tetsuhiro Chiba, Soichiro Kiyono and Kazufumi Kobayashi. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports, Clinical and Molecular Hepatology, JHEP Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.